Next Article in Journal
Agroprospecting of Biowastes: Globe Artichoke (Cynara scolymus L. Cultivar Tema, Asteraceae) as Potential Source of Bioactive Compounds
Previous Article in Journal
Multi-Functional Repair and Long-Term Preservation of Paper Relics by Nano-MgO with Aminosilaned Bacterial Cellulose
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antibacterial Efficacy and Characterization of Silver Nanoparticles Synthesized via Methanolic Extract of Fomes fomentarius L. Fr.

1
Department of Biology, University of Osijek, Cara Hadrijana 8A, 31000 Osijek, Croatia
2
Department of Chemistry, University of Osijek, Cara Hadrijana 8A, 31000 Osijek, Croatia
3
Department of Laboratory Medicine and Pharmacy, Faculty of Medicine in Osijek, University of Osijek, Josipa Huttlera 4, 31000 Osijek, Croatia
4
Faculty of Education, University of Osijek, Cara Hadrijana 10, 31000 Osijek, Croatia
*
Author to whom correspondence should be addressed.
Molecules 2024, 29(16), 3961; https://doi.org/10.3390/molecules29163961
Submission received: 25 July 2024 / Revised: 16 August 2024 / Accepted: 21 August 2024 / Published: 22 August 2024

Abstract

:
Green synthesis employs environmentally friendly, biodegradable substances for the production of nanomaterials. This study aims to develop an innovative method for synthesizing silver nanoparticles (AgNPs) using a methanolic extract of Fomes fomentarius L. Fr. as the reducing agent and to assess the potential antibacterial properties of the resulting nanoparticles. The successful synthesis of AgNPs was confirmed through characterization techniques such as UV-visible (UV-Vis) spectrophotometry, Fourier-transform infrared spectroscopy (FT-IR), and powder X-ray diffraction (PXRD). The UV-Vis analysis revealed an absorption peak at 423 nm, while FT-IR identified key phytochemical compounds involved in the reduction process. PXRD analysis indicated a face-centered cubic (fcc) structure with prominent peaks observed at 2θ = 38°, 44.6°, 64.6°, and 78°, confirming the crystalline nature of the AgNPs, with a crystallite diameter of approximately 24 nm, consistent with TEM analysis. The synthesized AgNPs demonstrated significant antibacterial activity, particularly against S. aureus, with higher efficacy against gram-positive bacteria.

1. Introduction

Due to their specific chemical, physical, and biological properties, nanoparticles, particularly silver nanoparticles (AgNPs), have garnered significant interest in medicine. They are widely used in nanobiotechnological research due to their catalytic and antibacterial activity [1]. They are of great importance due to increased surface relative to volume, altering the mechanical, catalytic, and thermal properties of materials [2]. AgNPs have demonstrated antimicrobial activity against different pathogenic microorganisms [3]. They have numerous applications in medicine, including wound dressing, as drug carriers and AgNPs-modified catheters, and also in diagnosis, detection, and imaging [4,5,6,7,8]. In agriculture, AgNPs are used against plant-pathogenic insects, fungi, bacteria, and viruses and as larvicidal agents [9,10,11,12].
Conventional techniques of nanoparticle synthesis sometimes involve the use of high-energy processes and dangerous chemicals, which can raise concerns about the environment and lead to the production of toxic byproducts. In contrast, by using bio-based materials including plants, microbes, and crop residue as environmentally friendly sources for nanoparticle synthesis, green synthesis methods offer an achievable solution [13]. The main benefits of green synthesis include large-scale manufacturing, an environmentally friendly method, a biological component that serves as the reducing agent, and energy savings as it requires no high pressure or energy [14,15]. It emphasizes the use of reagents that are non-toxic, ensuring that the chemical processes and their products are safe for both humans and the environment, and aiming to create sustainable, energy-efficient processes that preserve natural resources and protect ecosystems [16]. The three primary processes of green synthesis are as follows: choosing a suitable solvent, an environmentally safe reducing agent, and nontoxic compounds that stabilize nanoparticles [1].
Biogenic synthesis of silver nanoparticles (AgNPs) refers to the production of silver nanoparticles using biological organisms or their extracts [17,18,19,20,21]. This method is an eco-friendly and sustainable approach that leverages the natural reducing agents found in plants, fungi, bacteria, algae [22,23,24], or other biological sources such as honey [25] or media like cow, goat, or buffalo urine [26,27,28,29,30] to convert silver ions (Ag+) into silver nanoparticles (AgNPs). These sources contain natural compounds like carbohydrates (glucose, lactose, sucrose, fructose, cellulose, starch, and chitosan), proteins (collagen, enzymes, and albumin), amino acids, lipids, nucleic acid (DNA), and phenolic compounds that can act as reducing and stabilizing agents [31,32]. The reduction reaction leads to the formation of silver nanoparticles, which are then stabilized by the biomolecules present in the extract, preventing aggregation and controlling the size and shape of the nanoparticles [33].
Among fungal species, microscopic fungi are the most frequent producers, with about 6400 bioactive compounds exhibiting excellent antibacterial potency and usually low toxicity, while macrofungal species (Basidiomycetes) or mushrooms produce about 2000 active compounds [34]. Hoof fungus (Fomes fomentarius L. Fr.) is a woody macrofungus (mushroom) that thrives as a parasite or saprophyte on various deciduous tree species (beech, willow, poplar, linden, birch, beech, oak, maple, etc.), causing heart root of wood [35,36]. For generations, people have used Hoof fungus as a traditional natural cure for a wide range of illnesses and to improve digestion, reduce inflammation, boost the immune system, and heal bleeding wounds [37,38]. Additionally, it was applied to aid in weight loss and prevent stomach and esophageal cancer [38,39]. Numerous physiological activities, such as antibacterial, anti-inflammatory, antidiabetic, antioxidant, anticancer, and antiviral properties, are observed by this mushroom [38,40,41,42,43,44,45,46,47]. Water-soluble melanin–glucan complex (MGC) from F. fomentarius L. Fr. effectively inhibited Candida albicans, had strong antimicrobial effects on Helicobacter pylori, and displayed high anti-HIV-1 activity with low toxicity [43]. Fomes fomentarius L. Fr. also showed anti-herpes simplex virus 1 (HSV-1) activities [48]. Inhibitors of plant virus infection with systemic effects known as BAS (Basidiomycete Antiviral Substance) were found in the culture filtrates of F. fomentarius L. Fr. and were highly active against tobacco mosaic virus (TMV) without having toxic effects on host plants [49]. The conducted studies indicated the possibility of using exopolysaccharides from the F. fomentarius L. Fr. in the treatment of tumors and stomach ulcers since a direct antiproliferative effect in vitro on SGC-7901 human gastric cancer cells was observed [38]. Mushrooms growing on different types of wood, including species of the genus Fomes, can yield biomolecules with immunomodulating and antibacterial properties, such as terpenoids and glucans [38,39]. The dried F. fomentarius L. Fr. had a β-glucan content of 20.32 ± 0.3 g/100 g, suggesting a potentially rich source of these polysaccharides. For comparison, shiitake mushrooms as the most notable source of β-glucans had a content of 22 g/100 g [50]. Several classes of metabolites were isolated from F. fomentarius L. Fr. like esters and lactones, alcohols, ethers, peroxides, sterols, triterpenes, benzofurans, and coumarins [37,51,52,53,54,55]. Zhang and coworkers [56] isolated a total of 18 compounds, triterpenes, and erigosterols from F. fomentarius L. Fr. fruiting bodies. Many compounds showed cytotoxicities against six human cancer cell lines and inhibitory activities against nitric oxide (NO) production.
Various macrofungal species have shown great potential in biogenic synthesis, enabling the production of nanoparticles with diverse characteristics [57]. The synthesis of nanoparticles using fungal cell mass or extracellular components has many advantages. Fungal mycelium can withstand pressure, flow, agitation, and other phenomena in bioreactors. They are easy to grow and relatively easy to handle, and the precipitate containing nanoparticles lacks unnecessary components, allowing direct use [58]. To form silver nanoparticles, an extract containing intracellular or extracellular material is mixed with a metal salt solution, with silver nitrate being particularly effective. The reducing agents in the extract can include a combination of biomolecules such as enzymes, proteins, vitamins, flavonoids, amino acids, and alkaloids. Methanolic extracts of different mushrooms are widely recognized for their richness in polyphenols [59], which serve as effective reducing agents in nanoparticle synthesis. Previous research has shown that low molecular weight compounds (phenolic fractions) were efficiently extracted by methanol. Comparative studies have found higher concentrations of phenolic compounds in the methanolic extracts of C. versicolor than in its water and ethanol extract [60]. Similar findings were confirmed by Zengin et al. who demonstrated that the reducing capacity of Asphedoline anatolica extracts is greater in methanol than in water extracts [61]. Recent publications have confirmed that methanol extract contains significant amounts of polyphenolic compounds that could be active against H. pylori [50]. Therefore, in this study, the methanolic extract of Fomes fomentarius L. Fr. was used as methanol efficiently extracts low molecular weight phenolic compounds, enhancing the reducing capacity. No studies have been reported on the synthesis of silver nanoparticles using the methanolic extract of Fomes fomentarius L. Fr. and their antimicrobial activities. This novel approach leverages the reducing capacity of F. fomentarius L. Fr. methanolic extracts, offering a potentially more effective method for nanoparticle synthesis. By utilizing the methanolic extract of F. fomentarius L. Fr., this study aims to demonstrate the feasibility of using F. fomentarius L. Fr. in the green synthesis of silver nanoparticles, explore the potential antimicrobial applications of the synthesized nanoparticles, and contribute to the development of environmentally friendly methods for producing functional silver nanoparticles with significant biomedical and biotechnological applications.

2. Results and Discussion

2.1. Characterization of AgNPs Synthesized via F. fomentarius L. Fr. Extract

An initial indication that silver nanoparticles were formed by reducing Ag ions after being mixed with F. fomentarius L. Fr. extract was the change in color from yellow to brown (Figure S1A,B) [62], due to the excitation of surface plasmon vibrations in the nanoparticles [63,64,65]. AgNPs produced by extracts from Fomes fomentarius L. Fr. were examined in a colloidal solution using UV-visible spectroscopy. Figure 1. presents the UV-visible spectrum at specific time points, with the synthesized NPs’ absorbance maxima located at 423 nm. The creation of silver nanoparticles is indicated by the existence of a peak in the 300–500 nm region [64,66]. The UV-Vis spectra offer key information about the dimension, distribution, and form of nanoparticles. It is commonly known that surface plasmon resonances (SPRs), which shift to longer wavelengths with increasing particle size, dominate the optical absorption spectra of metal nanoparticles [67]. This phenomenon occurs when the conduction electrons on the nanoparticle surface resonate with the light wave, resulting in a distinct absorption peak. Furthermore, it is widely recognized that AgNP absorption is mostly influenced by size and shape [68]. The UV-Vis spectra’s lower wavelength maximum shows that the AgNPs that were generated had a smaller diameter; the longer wavelength suggests larger AgNPs [69], while the appearance of two or more maxima at longer wavelengths indicates the presence of large anisotropic nanoparticles [70]. The SPR bands centered between 420 and 430 nm of UV-Vis absorption spectra in Figure 1 align with the peak of silver. Silver nanoparticles exhibiting such SPR bands are expected to be between 10 and 30 nm in size with a spherical shape [71]. Generally speaking, when the nanoparticle’s symmetry rises, the number of SPR peaks drops [72].
Figure 1 exhibited a sharp, narrow, symmetric intense maximum at 423 nm, which indicates the formation of smaller-sized AgNPs. The absorption increased with time, indicating an increase in the number of formed AgNPs. The results of UV-Vis spectroscopy showed that the band located at approximately 423 nm exhibited no shift (bathochromic or hypsochromic) even after three months of measurement. The band maximum value remained constant, without any decrease in absorption maxima or any change in spectral features, which supports the stability of the AgNPs.
In order to identify the role of the biomolecules responsible for the reduction, FT-IR spectra were recorded in absorption mode between 400 and 4000 cm−1. The spectra of dried F. fomentarius L. Fr. extract and AgNPs after reaction with AgNO3 are represented in Figure 2. The control spectrum showed several peaks indicating the complex nature of F. fomentarius L. Fr. extract.
The shifting in wavenumber or changes in peak intensity explains the types of functional groups involved in the binding mechanisms. The FTIR spectrum for F. fomentarius L. Fr. dried extract showed absorption bands at 3295, 2929, 1654, 1541 cm−1, and 1043 cm−1, which were assigned to the O-H linkage of phenolic and hydroxylic groups, C-H stretching vibrations of aliphatic compounds, N-C=O amide I band of proteins, amide II band of proteins, and C-H stretching vibrations of polysaccharides in F. fomentarius L. Fr. extract. After reaction with AgNO3, there was a shift in the following bands, at 3295 to 3288, 2929 to 2919, 1654 to 1647, 1541 to 1537 cm−1, and 1043 to 1035 cm−1, indicating that these naturally present organic substances take a key part in stabilization and reduction of Ag+. The absorption band at approximately 521 cm−1 is not observed in the spectrum of F. fomentarius L. Fr. extract. According to Wan Mat Khalir et al., 2020, the absorption peak at approximately 521 cm−1 is related to the Ag-O band [73]. According to previous research, the F. fomentarius L. Fr. extract is mostly composed of phenolics, carbohydrates, minerals, crude fat, low amounts of proteins, chitin, and paulownin [50,54,74,75]. With β-glucan representing about one-third of the total carbohydrates, along with phenolic compounds like humic acid, lignin, and melanin establishing up the most valuable essential part of the extract [74], the functional groups linked to these biomolecules may contribute to the reduction of Ag+ in Ag° [76].
Further confirmation of the presence of the AgNPs was shown by a PXRD image (Figure 3). The results of PXRD clearly illustrated that synthesized silver nanoparticles are crystalline in nature. The representative PXRD pattern of silver nanoparticles formed after reaction of F. fomentarius L. Fr. extract with AgNO3 shows the five main peaks observed at 2θ values of 38°, 44.6°, 64.6°, 78°, and 81.5° and are indexed as (111), (200), (220), (311), and (222) crystallographic planes of the face-centered cubic (FCC) structure of silver. The average crystallite size was calculated using Scherrer’s Equation (1):
D = k λ β 0.5 c o s θ
where D is crystallite size, λ is wavelength (1.54056 Å), β0.5 (FWHM-full width of half maximum), k is the Scherrer constant, and θ is the Bragg angle. According to the PXRD results, the synthesized AgNPs attained a size of about 24 nm.
The size and morphology of the synthesized AgNPs were further analyzed by TEM analysis, which revealed that the AgNPs were primarily spherical in shape (Figure 4A). Their size ranges between 16 and 29 nm, and the particle diameter distribution histogram indicated that the average particle size was 23.6 ± 3.5 (Figure 4C).
The crystallite size obtained from TEM analysis was consistent with the crystallite size measured by PXRD. As a result, despite a few small agglomerations shown in Figure 4A, the Ag nanoparticles produced using methanolic extracts of F. fomentarius L. Fr. are evenly dispersed. The observed clusters may be due to aggregation during sample preparation, which could have also contributed to the reduced clarity and detail in the TEM image. We acknowledge this as a limitation of our analysis and have transparently addressed it in this study. To improve the clarity and boundary definition of the silver nanoparticles, the ‘Find Edges’ option in the Fiji program was applied (Figure 4B). This technique enhances image sharpness by highlighting the edges of the nanoparticles, making it easier to distinguish individual particles from the background. Such enhancement is particularly useful when analyzing the morphology and size distribution of nanoparticles.
This study successfully demonstrated the synthesis of silver nanoparticles (AgNPs) using the methanolic extract of Fomes fomentarius L. Fr. However, limitations remain in fully characterizing the crystalline structure. The rationale for selecting UV-visible spectroscopy, FT-IR, and PXRD lies in their proven efficacy in nanoparticle research and wide recognition and consistent use in nanoparticle research. Although they were effective in confirming nanoparticle formation, size, shape, and identifying functional groups, they do not fully capture the electronic states and surface chemistry crucial for understanding interactions with biological systems. UV-visible spectroscopy is essential for detecting nanoparticle formation, as evidenced by the SPR peak at 423 nm, indicating small, spherical AgNPs. This method is also rapid and non-destructive, allowing for the monitoring of AgNP stability over time. FT-IR was employed to identify the specific biomolecules from the Fomes fomentarius extract that facilitated the reduction of silver ions and the subsequent stabilization of AgNPs, with shifts in absorption bands indicating interactions between silver ions and functional groups like phenolic and hydroxyl groups, which are known to play active roles in the reduction process. PXRD was used to confirm the crystalline nature and phase purity of the synthesized AgNPs, with diffraction peaks at specific 2θ values indicating a face-centered cubic (fcc) structure, and crystallite size estimated using the Scherrer equation. PXRD is a robust technique for determining the crystal structure and size of nanoparticles, making it a standard choice in nanoparticle characterization.
Given equipment limitations, these key techniques provided substantial insights into the properties of the synthesized AgNPs. However, to further enhance understanding and broaden potential applications, future studies could incorporate additional characterization techniques. Dynamic Light Scattering (DLS) could be used to analyze the hydrodynamic size and zeta potential of the nanoparticles in colloidal suspension, with zeta potential being particularly important for assessing nanoparticle stability in various environments. Energy Dispersive X-ray Spectroscopy (EDX) coupled with TEM could provide elemental analysis and mapping of the nanoparticles, offering more precise information about composition and purity. While TEM was employed in this study, incorporating electron diffraction or X-ray photoelectron spectroscopy (XPS) in future studies would strengthen understanding of the relationship between silver’s oxidation states and the nature of its interaction with biomolecules from the extract, further validating the findings from PXRD and UV-Vis spectroscopy.

2.2. Antibacterial Activity of AgNPs Synthesized via F. fomentarius L. Fr. Extract

The results indicated that the initial methanolic F. fomentarius L. Fr. extract exhibited significant antibacterial activity, showing the highest efficacy against E. coli, with an MIC value of 2.63 mg mL−1, less potency against S. aureus, with an MIC value of 10.41 mg mL−1, and the least activity against B. subtilis and P. aeruginosa, both with an MIC value of 20.83 mg mL−1 (Table 1).
These findings are in contrast with previous studies. For instance, Kolundžić et al. (2016) [50] reported an MIC value of 125 µg mL−1 against E. coli, S. aureus, B. subtilis, and P. aeruginosa, indicating broad-spectrum activity with a higher potency than that observed in our study. Dundar et al. (2016) [77] found that their extract did not exhibit activity against B. subtilis and E. coli, but it showed a 4 mm inhibition zone against S. aureus and an 8 mm inhibition zone against P. aeruginosa. This suggests that the methanolic F. fomentarius L. Fr. extract used in our study may possess a unique composition or higher concentration of active compounds that confer better efficacy, especially against E. coli. On the other hand, İrez et al. (2021) [78] reported that their methanolic extract was most effective against B. subtilis and E. coli, with a remarkably low MIC value of 2.5 µg mL−1, which is significantly more potent than our findings. The variations in antibacterial activity across these studies may be attributed to differences in extraction methods or the source and concentration of bioactive compounds.
However, the silver nanoparticles demonstrated independent antibacterial properties. The AgNPs synthesized using the methanolic extract of F. fomentarius L. Fr. demonstrated antibacterial activities against E. coli, P. aeruginosa, B. subtilis, and S. aureus (Table 1). The AgNPs were most active against S. aureus, with an MIC value of 6.34 µg mL−1. In addition, AgNPs were active against E. coli, P. aeruginosa, and B. subtilis, with no differences in activity, each having an MIC value of 12.69 µg mL−1.
These results support several earlier studies that have shown the antibacterial efficacy of AgNPs biosynthesized utilizing mushrooms. Using water extracts of Pleurotus giganteus, a wild edible mushroom, Debnath et al. (2019) [79] synthesized AgNPs with MIC values of 12, 10, 14, and 15 μg/mL against E. coli, P. aeruginosa, B. subtilis, and S. aureus, respectively.
Zhang et al. (2020) [80] synthesized silver nanoparticles (AgNPs) using Flammulina velutipes mushroom extract. TEM analysis showed monodispersed spherical AgNPs averaging 22 nm, while X-ray diffraction confirmed their face-centered cubic crystalline structure and showed excellent stability and antibacterial efficacy against six aquatic pathogens. Extract from reishi mushrooms Ganoderma lucidum was used to synthesize AgNPs by Aygün et al. (2020) [81]. TEM images revealed spherical AgNPs with diameters of 15–22 nm, and a face-centered cubic structure was verified by XRD. The AgNPs showed significant antibacterial action against gram-positive (S. aureus, E. hirae, B. cereus) and gram-negative (E. coli, P. aeruginosa, L. pneumophila subsp. pneumophila) bacteria. Additionally, they demonstrated a significant level of antifungal activity against the C. albicans fungus. A variety of different studies have been carried out regarding the production of silver nanoparticles from fungal organisms, including Verticillium sp., Fusarium semitectum, Penicillium sp., Aspergillus niger, A. terreus, etc. [82,83,84,85,86]. To our knowledge, this is the first report of the effective synthesis of mushroom-mediated AgNPs using a methanolic extract of Fomes fomentarius L. Fr.
Numerous researchers have documented AgNPs’ antimicrobial activity. Nonetheless, a significant degree of variance was seen in the MIC values from the earlier investigations. Because diverse approaches have been used by the researchers and there are different methods for determining the antibacterial activity of AgNPs, it is challenging to compare the results. When compared to the results from the literature, the AgNPs synthesized in this study using F. fomentarius L. Fr. extract show significant potency. For instance, the MIC value of AgNPs against E. coli was 65 µg mL−1, against P. aeruginosa, it was 75 µg mL−1, against B. subtilis, it was 180 µg mL−1, and against S. aureus, it was 85 µg mL−1, as demonstrated by Devanesan and Alsahi (2021) [87]. While several studies have previously reported on the antimicrobial activity and potential action mechanisms of silver nanoparticles (AgNPs), our findings represent exceptionally strong antistaphylococcal activity exhibited by AgNPs. It has been previously highlighted that the relatively small size of the spherical Ag nanoparticles is conducive to determining their considerable antimicrobial activity [88]. Various antibacterial action mechanisms are thought to be useful in restricting bacterial growth. First, AgNP surfaces go through a number of processes, including aggregation, disintegration, photochemical reactions, and the Ag ions’ discharge. Second, AgNPs engage with the phosphorus moiety in bacterial DNA, which inactivates replication and ultimately causes bacterial cell death by impeding bacterial growth. This interaction also occurs with bacterial cell walls, impairing the normal function of bacterial proteins. However, AgNPs’ physical and chemical characteristics, size, shape, and ligand chemistry, in addition to the medium, bacterial habitat, and concentration, all have an impact on their antibacterial activity [89,90].
Although this study demonstrated the significant antibacterial activity of AgNPs synthesized using the methanolic extract of Fomes fomentarius L. Fr., it did not investigate the specific molecular mechanisms underlying their interaction with bacterial cells or the specific mechanisms of action, such as the generation of reactive oxygen species [91] or the potential disruption of bacterial biofilms [92]. Future research using advanced techniques like proteomics, transcriptomics, and metabolomics could provide deeper insights into how AgNPs disrupt bacterial cell function at the molecular level [93,94]. Additionally, employing electron microscopy, fluorescence microscopy, and other imaging techniques could visualize AgNP interactions with bacterial cells and biofilms in real-time. In vivo studies in animal models could be conducted to assess the biodistribution, pharmacokinetics, and long-term effects of AgNPs. Furthermore, future studies should evaluate the ecological impact of AgNP release into the environment, focusing on effects on non-target organisms and ecosystems. Developing strategies to minimize environmental contamination, such as recycling or safe disposal of AgNPs, is crucial for sustainable development.
Fomes fomentarius L. Fr. has garnered our attention for green nanoparticle synthesis due to its unique properties and potential advantages, including sustainability, cost-effectiveness, biocompatibility, and efficiency. As a widely available, renewable, and biodegradable resource, it represents an environmentally friendly option for nanoparticle production. This mushroom contains natural compounds like polysaccharides, polyphenols, and proteins, which can be utilized as stabilizing and reducing agents in the synthesis of silver nanoparticles. The application prospects of AgNPs synthesized using F. fomentarius are substantial and promising, particularly in several industrial and medical domains. In the field of catalysis, these AgNPs could serve as highly efficient catalysts for various chemical reactions due to their large surface area and enhanced reactivity, potentially revolutionizing processes in the chemical industry. In water purification, AgNPs produced through this green synthesis method could be employed to remove contaminants, including pathogens, heavy metals, and organic pollutants, thereby contributing to safer and cleaner water sources [95,96]. Medically, the biocompatibility [97] and antimicrobial properties of these AgNPs provide opportunities for applications in wound healing, biomarker detection, and targeted drug delivery systems. Their potential to be used in diagnostic tools, such as biosensors for detecting specific biomarkers [98], could lead to advancements in early disease detection and personalized medicine. Furthermore, the ability of these nanoparticles to be customized for targeted drug delivery presents options in cancer therapy [99], where they could deliver therapeutic agents directly to tumor cells, minimizing side effects on healthy tissues.
Given the growing concern about environmental sustainability and the need for greener technologies, the use of F. fomentarius L. Fr. in AgNP synthesis aligns with the increasing global focus on more sustainable practices. The ability to produce AgNPs with specific properties for various applications highlights the agility and potential of this method. Future research focused on optimizing the synthesis process, expanding production, and rigorously evaluating the environmental and health impacts will be crucial in transitioning these promising applications from the laboratory to industrial and clinical settings.

3. Materials and Methods

3.1. Collection of Fomes fomentarius L. Fr.

Fomes fomentarius (L.) Fr. was collected in the Osijek-Baranja County area (45.61731317289811, 18.50216958907446) from the beech tree Fagus sylvatica (L.) (Figure 5). Samples were transported to the laboratory for an extensive morphometric analysis after being appropriately labeled and assigned a voucher number. Using standard keys field guides and manuals, specimens were identified by careful study of characteristics. After being dried, the specimen was deposited at the Department of Chemistry, University of Osijek, Croatia.

3.2. Preparation of AgNPs

Dried F. fomentarius L. Fr. were ground with laboratory mill SM-450 (MRC Laboratory Equipment Manufacturer, Holon, Israel) into a powder, and 25 g of this powder was mixed with 150 mL 70% methanol. The mixture was then placed in an ultrasonic bath (Sonorex Digitec DT 510 H-RC, Bandelin electronic GmbH & Co. KG, Berlin, Germany) for 30 min. After sonication, the sample was left for 48 h in a dark place at room temperature (22 °C). Following this period, the mixture was filtered using Whatman No. 1 filter paper and evaporated. A portion of 0.100 g of the crude extract was mixed with 10 mL demineralized water and stirred for 30 min. Subsequently, 10 mL of this mixture was mixed with 90 mL of 1 mM AgNO3 and the pH was adjusted from 4.9 to 7 using 0.2 M NaOH. This mixture was placed in a shaking bath (Memmert Water Bath WNB 22 with Memmert SV 1422 Shaking Device, Memmert GmbH + Co. KG, Nürnberg, Germany) at 80 °C until a color change was observed. The reaction mixture’s color changed from yellow to reddish brown (Figure S1A,B), signifying the reduction of silver ions to elemental silver. The resulting mixture was centrifuged for 45 min at 2000 rpm (Centrifuge Tehtnica Centric 322 A, Domel d.o.o., Slovenia) to separate AgNPs. The AgNPs were then re-dispersed in demineralized water and subjected to three additional washing steps via repeated centrifugations at 2000 rpm for 45 min to ensure the removal of any free bioactive compounds from F. fomentarius. After each round of centrifugation, the supernatant was analyzed using UV-Vis spectroscopy to confirm the absence of AgNO3. The resulting pellets were then dried at room temperature (22–24 °C) for 96 h. These thoroughly purified and dried samples were subsequently used for Powder X-ray Diffraction (PXRD), Transmission Electron Microscopy (TEM) analyses, and antibacterial testing. In this study, the optimal parameters for silver nanoparticle synthesis were determined to be 1 mM AgNO3, a temperature of 80 °C, a 1:9 extract to AgNO3 solution ratio, and a pH of 7.

3.3. Characterization of AgNPs

The UV-Vis spectra of the synthesized AgNPs were collected using a UV-1900 Shimadzu spectrophotometer (Shimadzu Corporation, Kyoto, Japan) over a spectral range of 350–700 nm with a 1 cm cuvette. The FT-IR spectra, ranging from 400 to 4000 cm−1, were acquired using an FT-IR 8400s Shimadzu spectrometer (Shimadzu Corporation, Kyoto, Japan). After FT-IR analysis, powder X-ray diffraction (PXRD) patterns were obtained using a Panalytical Aeris X-ray diffractometer (Malvern Panalytical Ltd., Malvern, UK). The Transmission Electron Microscopy (TEM) analysis was performed using JEOL JEM 1200EX II TEM (Jeol Ltd., Tokyo, Japan) at the Institute of Pharmaceutical Technology and Biopharmacy, Medical School, University of Pécs, Hungary. For TEM analysis, samples were placed on the 200 mesh Butvar B-98-coated copper grid (Micro to Nano Ltd., Haarlem, The Netherlands). The software ImageJ 1.54f was used to estimate the diameters of visualized AgNPs.

3.4. Antibacterial Activity of AgNPs

Using a modified broth microdilution method, a minimum inhibitory concentration (MIC) test was used to evaluate the antibacterial capabilities of silver nanoparticles [100] against four different bacterial strains: Gram-negative Pseudomonas aeruginosa, Escherichia coli, and Gram-positive Bacillus subtilis and Staphylococcus aureus. The bacterial strains in consideration were isolated from a range of clinical samples acquired from the Institute of Public Health Osijek, situated in Osijek-Baranja County, Croatia, and operated by the Microbiology Service. Polypropylene flat sterile 96-well microtiter plates (Kartell Labware, Noviglio (MI), Italy) were used for the broth microdilution assays. Bacterial subcultures (5 × 105 CFU mL−1) in Mueller Hinton Broth (Cultimed, Barcelona, Spain) were added to dual serial diluted synthesized AgNPs, which were resuspended in methanol for this microdilution method. Each plate had wells with a bacterial subculture without AgNPs for growth control and wells with just broth and methanol for solvent (continuous phase) control. Additionally, we conducted an antibacterial assay for the initial methanolic extract of Fomes fomentarius L. Fr. itself. Under identical conditions, a co-assay was conducted using the antibiotic ciprofloxacin (Hospira, Hurley, Maidenhead, Berkshire, England, UK). Triphenyl tetrazolium chloride (VWR Chemicals, Leuven, Belgium) served as a bacterial growth indicator during an extra three-hour incubation period at 37 °C following a 24-h incubation period at the same temperature. The minimum inhibitory concentration (MIC) was determined as the lowest concentration of the AgNPs, obtained from triplicate analyses normalized against the solvent control.

4. Conclusions

This study successfully demonstrated the green synthesis of silver nanoparticles (AgNPs) using the methanolic extract of Fomes fomentarius L. Fr. The synthesized AgNPs were thoroughly characterized, with UV-Vis spectroscopy confirming their formation through a sharp absorption peak at 423 nm. FT-IR analysis identified the key biomolecules responsible for the reduction and stabilization of the nanoparticles, while PXRD analysis confirmed their crystalline nature, showing a face-centered cubic (fcc) structure with an average crystallite size of approximately 24 nm, in accordance with TEM analysis. The antibacterial efficacy of the synthesized AgNPs was evident, particularly against S. aureus, with the nanoparticles showing higher activity against gram-positive bacteria. This positions the AgNPs synthesized using Fomes fomentarius L. Fr. as a promising candidate for applications in antibacterial treatments, particularly in targeting resistant bacterial strains.
While this study provides significant insights into the potential of Fomes fomentarius L. Fr. in the synthesis of functional AgNPs, it also highlights the need for further research. The study’s limitations emphasize the necessity of employing additional characterization techniques such as Dynamic Light Scattering (DLS) and X-ray Photoelectron Spectroscopy (XPS) in future research. These techniques could offer a deeper understanding of the surface chemistry and stability of the nanoparticles, which are critical for their application in biomedical and biotechnological fields. Additionally, investigating the specific molecular mechanisms of interaction between the AgNPs and bacterial cells, including the generation of reactive oxygen species and the potential disruption of bacterial biofilms, continues to be an important topic for research.
In conclusion, this study not only introduces a novel approach to AgNP synthesis using Fomes fomentarius L. Fr. but also provides the basis for future research intended to enhance the characterization and application of these nanoparticles. The findings contribute to the expanding data on the green synthesis of nanoparticles, emphasizing the potential of mushrooms as a sustainable and effective source for nanoparticle production.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules29163961/s1, Figure S1: (A) Fomes fomentarius L. Fr. methanolic extract before and (B) after the addition of 1 mM AgNO3; Figure S2: Original unprocessed Transmission Electron Microscopy (TEM) image of silver nanoparticles (AgNPs) synthesized using methanolic extract of Fomes fomentarius L. Fr., obtained using a JEM 1200EX II Transmission Electron Microscope.

Author Contributions

Conceptualization, V.G. and V.P.; methodology, V.G., S.R. and V.P.; software, V.G.; validation, E.K.-A., I.Ć. and Z.U.; formal analysis, V.G. and I.Ć.; investigation, V.G. and V.P.; resources, V.G. and E.K.-A.; data curation, E.K.-A.; writing—original draft preparation, V.G. and V.P.; writing—review and editing, V.P.; visualization, V.P.; supervision, E.K.-A.; funding acquisition, Z.U. All authors have read and agreed to the published version of the manuscript.

Funding

Part of this research was funded by the internal Scientific research project of the Department of Chemistry, University of Osijek (no. 5115). The second part of this research was funded by the internal Scientific research project of the Department of Biology, University of Osijek (no. 3015-12-22).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

We would like to thank Aleksandar Sečenji for his technical support in the TEM analysis.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Sharma, V.K.; Yngard, R.A.; Lin, Y. Silver Nanoparticles: Green Synthesis and Their Antimicrobial Activities. Adv. Colloid. Interface Sci. 2009, 145, 83–96. [Google Scholar] [CrossRef] [PubMed]
  2. Firdhouse, M.J.; Lalitha, P. Biosynthesis of Silver Nanoparticles and Its Applications. J. Nanotechnol. 2015, 2015, 829526. [Google Scholar] [CrossRef]
  3. Bruna, T.; Maldonado-Bravo, F.; Jara, P.; Caro, N. Silver Nanoparticles and Their Antibacterial Applications. Int. J. Mol. Sci. 2021, 22, 7202. [Google Scholar] [CrossRef]
  4. Huy, T.Q.; Van, N.Q.; Anh-Tuan, L. Silver Nanoparticles: Synthesis, Properties, Toxicology, Applications and Perspectives. Adv. Nat. Sci. Nanosci. Nanotechnol. 2013, 4, 033001. [Google Scholar] [CrossRef]
  5. Ge, L.; Li, Q.; Wang, M.; Ouyang, J.; Li, X.; Xing, M.M. Nanosilver Particles in Medical Applications: Synthesis, Performance, and Toxicity. Int. J. Nanomed. 2014, 9, 2399–2407. [Google Scholar] [CrossRef]
  6. Tian, J.; Wong, K.K.Y.; Ho, C.-M.; Lok, C.-N.; Yu, W.-Y.; Che, C.-M.; Chiu, J.-F.; Tam, P.K.H. Topical Delivery of Silver Nanoparticles Promotes Wound Healing. ChemMedChem 2007, 2, 129–136. [Google Scholar] [CrossRef] [PubMed]
  7. Alabresm, A.; Chen, Y.P.; Wichter-Chandler, S.; Lead, J.; Benicewicz, B.C.; Decho, A.W. Nanoparticles as Antibiotic-Delivery Vehicles (ADVs) Overcome Resistance by MRSA and Other MDR Bacterial Pathogens: The Grenade Hypothesis. J. Glob. Antimicrob. Resist. 2020, 22, 811–817. [Google Scholar] [CrossRef]
  8. Huy, T.Q.; Huyen, P.T.M.; Le, A.-T.; Tonezzer, M. Recent Advances of Silver Nanoparticles in Cancer Diagnosis and Treatment. Anti-Cancer Agents Med. Chem. 2020, 20, 1276–1287. [Google Scholar] [CrossRef]
  9. Mansoor, S.; Zahoor, I.; Baba, T.R.; Padder, S.A.; Bhat, Z.A.; Koul, A.M.; Jiang, L. Fabrication of Silver Nanoparticles Against Fungal Pathogens. Front. Nanotechnol. 2021, 3, 679358. [Google Scholar] [CrossRef]
  10. Shanmugasundaram, T.; Balagurunathan, R. Mosquito Larvicidal Activity of Silver Nanoparticles Synthesised Using Actinobacterium, Streptomyces Sp. M25 against Anopheles Subpictus, Culex Quinquefasciatus and Aedes Aegypti. J. Parasit. Dis. 2015, 39, 677–684. [Google Scholar] [CrossRef]
  11. dos Santos, O.A.L.; dos Santos, M.S.; Antunes Filho, S.; Backx, B.P. Nanotechnology for the Control of Plant Pathogens and Pests. Plant Nano Biol. 2024, 8, 100080. [Google Scholar] [CrossRef]
  12. Khan, S.; Zahoor, M.; Khan, R.S.; Ikram, M.; Islam, N.U. The Impact of Silver Nanoparticles on the Growth of Plants: The Agriculture Applications. Heliyon 2023, 9, e16928. [Google Scholar] [CrossRef] [PubMed]
  13. Osman, A.I.; Zhang, Y.; Farghali, M.; Rashwan, A.K.; Eltaweil, A.S.; Abd El-Monaem, E.M.; Mohamed, I.M.A.; Badr, M.M.; Ihara, I.; Rooney, D.W.; et al. Synthesis of Green Nanoparticles for Energy, Biomedical, Environmental, Agricultural, and Food Applications: A Review. Environ. Chem. Lett. 2024, 22, 841–887. [Google Scholar] [CrossRef]
  14. Singh, J.; Dutta, T.; Kim, K.-H.; Rawat, M.; Samddar, P.; Kumar, P. ‘Green’ Synthesis of Metals and Their Oxide Nanoparticles: Applications for Environmental Remediation. J. Nanobiotechnol. 2018, 16, 84. [Google Scholar] [CrossRef]
  15. Nguyen, N.P.U.; Dang, N.T.; Doan, L.; Nguyen, T.T.H. Synthesis of Silver Nanoparticles: From Conventional to ‘Modern’ Methods—A Review. Processes 2023, 11, 2617. [Google Scholar] [CrossRef]
  16. Wardencki, W.; Curyło, J.; Namieśnik, J. Green Chemistry—Current and Future Issues. Pol. J. Environ. Stud. 2005, 14, 389–395. [Google Scholar]
  17. Rozhin, A.; Batasheva, S.; Kruychkova, M.; Cherednichenko, Y.; Rozhina, E.; Fakhrullin, R. Biogenic Silver Nanoparticles: Synthesis and Application as Antibacterial and Antifungal Agents. Micromachines 2021, 12, 1480. [Google Scholar] [CrossRef]
  18. Alex, A.M.; Subburaman, S.; Chauhan, S.; Ahuja, V.; Abdi, G.; Tarighat, M.A. Green Synthesis of Silver Nanoparticle Prepared with Ocimum Species and Assessment of Anticancer Potential. Sci. Rep. 2024, 14, 11707. [Google Scholar] [CrossRef]
  19. Ahmadi, F.; Lackner, M. Green Synthesis of Silver Nanoparticles from Cannabis Sativa: Properties, Synthesis, Mechanistic Aspects, and Applications. ChemEngineering 2024, 8, 64. [Google Scholar] [CrossRef]
  20. Khan, A.; Ahmad, N.; Fazal, H.; Ali, M.; Akbar, F.; Khan, I.; Tayyab, M.; Uddin, M.N.; Ahmad, N.; Abdel-Maksoud, M.A.; et al. Biogenic Synthesis of Silver Nanoparticles Using Rubus Fruticosus Extract and Their Antibacterial Efficacy against Erwinia Caratovora and Ralstonia Solanacearum Phytopathogens. RSC Adv. 2024, 14, 5754–5763. [Google Scholar] [CrossRef]
  21. Korkmaz, N.; Ceylan, Y.; İmamoğlu, R.; Kısa, D.; Şen, F.; Karadağ, A. Eco-Friendly Biogenic Silver Nanoparticles: Synthesis, Characterization and Biological Applications. Int. J. Environ. Sci. Technol. 2024. [Google Scholar] [CrossRef]
  22. Jayaprakash, N.; Vijaya, J.J.; Kaviyarasu, K.; Kombaiah, K.; Kennedy, L.J.; Ramalingam, R.J.; Munusamy, M.A.; Al-Lohedan, H.A. Green Synthesis of Ag Nanoparticles Using Tamarind Fruit Extract for the Antibacterial Studies. J. Photochem. Photobiol. B 2017, 169, 178–185. [Google Scholar] [CrossRef] [PubMed]
  23. Konishi, Y.; Ohno, K.; Saitoh, N.; Nomura, T.; Nagamine, S.; Hishida, H.; Takahashi, Y.; Uruga, T. Bioreductive Deposition of Platinum Nanoparticles on the Bacterium Shewanella Algae. J. Biotechnol. 2007, 128, 648–653. [Google Scholar] [CrossRef]
  24. Yadav, A.; Kon, K.; Kratosova, G.; Duran, N.; Ingle, A.P.; Rai, M. Fungi as an Efficient Mycosystem for the Synthesis of Metal Nanoparticles: Progress and Key Aspects of Research. Biotechnol. Lett. 2015, 37, 2099–2120. [Google Scholar] [CrossRef]
  25. Bahari, N.; Hashim, N.; Abdan, K.; Md Akim, A.; Maringgal, B.; Al-Shdifat, L. Role of Honey as a Bifunctional Reducing and Capping/Stabilizing Agent: Application for Silver and Zinc Oxide Nanoparticles. Nanomaterials 2023, 13, 1244. [Google Scholar] [CrossRef]
  26. Srikar, S.K.; Giri, D.D.; Pal, D.B.; Mishra, P.K.; Upadhyay, S.N. Green Synthesis of Silver Nanoparticles: A Review. Green Sustain. Chem. 2016, 6, 34–56. [Google Scholar] [CrossRef]
  27. Al-Zaban, M.I.; Mahmoud, M.A.; AlHarbi, M.A. Catalytic Degradation of Methylene Blue Using Silver Nanoparticles Synthesized by Honey. Saudi J. Biol. Sci. 2021, 28, 2007–2013. [Google Scholar] [CrossRef]
  28. Santhosh, A.S.; Sandeep, S.; Manukumar, H.M.; Mahesh, B.; Kumara Swamy, N. Green Synthesis of Silver Nanoparticles Using Cow Urine: Antimicrobial and Blood Biocompatibility Studies. JCIS Open 2021, 3, 100023. [Google Scholar] [CrossRef]
  29. Raghavendra, S.N.; Raghu, H.S.; Chaithra, C.; Rajeshwara, A.N. Potency of Mancozeb Conjugated Silver Nanoparticles Synthesized from Goat, Cow and Buffalo Urine Against Colletotrichum Gloeosporioides Causing Anthracnose Disease. NEPT 2020, 19, 969–979. [Google Scholar] [CrossRef]
  30. Rattan, R.; Shukla, S.; Sharma, B.; Bhat, M. A Mini-Review on Lichen-Based Nanoparticles and Their Applications as Antimicrobial Agents. Front. Microbiol. 2021, 12, 633090. [Google Scholar] [CrossRef]
  31. Sidhu, A.K.; Verma, N.; Kaushal, P. Role of Biogenic Capping Agents in the Synthesis of Metallic Nanoparticles and Evaluation of Their Therapeutic Potential. Front. Nanotechnol. 2022, 3, 801620. [Google Scholar] [CrossRef]
  32. Zuhrotun, A.; Oktaviani, D.J.; Hasanah, A.N. Biosynthesis of Gold and Silver Nanoparticles Using Phytochemical Compounds. Molecules 2023, 28, 3240. [Google Scholar] [CrossRef]
  33. Siakavella, I.K.; Lamari, F.; Papoulis, D.; Orkoula, M.; Gkolfi, P.; Lykouras, M.; Avgoustakis, K.; Hatziantoniou, S. Effect of Plant Extracts on the Characteristics of Silver Nanoparticles for Topical Application. Pharmaceutics 2020, 12, 1244. [Google Scholar] [CrossRef] [PubMed]
  34. Bérdy, J. Bioactive Microbial Metabolites. J. Antibiot. 2005, 58, 1–26. [Google Scholar] [CrossRef]
  35. Suvorov, P.A. Biological Characteristics of Fomes fomentarius, Found on Spruce and Birch. Can. J. Bot. 1967, 45, 1853–1857. [Google Scholar] [CrossRef]
  36. Lira Dyson, B.; Herpel, R.; Karasch, P.; Müller, J.; Thom, D.; Bässler, C. Effects of Forest Management on the Key Fungal Decomposer Fomes fomentarius in European Beech Forests—Lessons from a Large-Scale Experiment. For. Ecol. Manag. 2024, 552, 121580. [Google Scholar] [CrossRef]
  37. Grienke, U.; Zöll, M.; Peintner, U.; Rollinger, J.M. European Medicinal Polypores--a Modern View on Traditional Uses. J. Ethnopharmacol. 2014, 154, 564–583. [Google Scholar] [CrossRef] [PubMed]
  38. Chen, W.; Zhao, Z.; Chen, S.-F.; Li, Y.-Q. Optimization for the Production of Exopolysaccharide from Fomes fomentarius in Submerged Culture and Its Antitumor Effect In Vitro. Bioresour. Technol. 2008, 99, 3187–3194. [Google Scholar] [CrossRef]
  39. Wasser, S.P. Medicinal Mushroom Science: History, Current Status, Future Trends, and Unsolved Problems. IJM 2010, 12, 1–16. [Google Scholar] [CrossRef]
  40. Kim, S.H.; Jakhar, R.; Kang, S.C. Apoptotic Properties of Polysaccharide Isolated from Fruiting Bodies of Medicinal Mushroom Fomes fomentarius in Human Lung Carcinoma Cell Line. Saudi J. Biol. Sci. 2015, 22, 484–490. [Google Scholar] [CrossRef]
  41. Lee, S.-O.; Lee, M.-H.; Lee, K.-R.; Lee, E.-O.; Lee, H.-J. Fomes fomentarius Ethanol Extract Exerts Inhibition of Cell Growth and Motility Induction of Apoptosis via Targeting AKT in Human Breast Cancer MDA-MB-231 Cells. Int. J. Mol. Sci. 2019, 20, 1147. [Google Scholar] [CrossRef]
  42. Park, Y.-M.; Kim, I.-T.; Park, H.-J.; Choi, J.-W.; Park, K.-Y.; Lee, J.-D.; Nam, B.-H.; Kim, D.-G.; Lee, J.-Y.; Lee, K.-T. Anti-Inflammatory and Anti-Nociceptive Effects of the Methanol Extract of Fomes fomentarius. Biol. Pharm. Bull. 2004, 27, 1588–1593. [Google Scholar] [CrossRef] [PubMed]
  43. Seniuk, O.F.; Gorovoj, L.F.; Beketova, G.V.; Savichuk, H.O.; Rytik, P.G.; Kucherov, I.I.; Prilutskay, A.B.; Prilutsky, A.I. Anti-Infective Properties of the Melanin-Glucan Complex Obtained from Medicinal Tinder Bracket Mushroom, Fomes fomentarius (L.: Fr.) Fr. (Aphyllophoromycetideae). Int. J. Med. Mushrooms 2011, 13, 7–18. [Google Scholar] [CrossRef] [PubMed]
  44. Ravnikar, M.; Štrukelj, B.; Otašević, B.; Sirše, M. Fomentariol, a Fomes fomentarius Compound, Exhibits Anti-Diabetic Effects in Fungal Material: An In Vitro Analysis. Nutraceuticals 2024, 4, 273–282. [Google Scholar] [CrossRef]
  45. Seo, D.-W.; Yi, Y.-J.; Lee, M.-S.; Yun, B.-S.; Lee, S.-M. Differential Modulation of Lipopolysaccharide-Induced Inflammatory Cytokine Production by and Antioxidant Activity of Fomentariol in RAW264.7 Cells. Mycobiology 2015, 43, 450–457. [Google Scholar] [CrossRef] [PubMed]
  46. Karadeniz, M.; Bakır, T.K.; Ünal, S. Investigation of the Antioxidant and Total Phenolic Substance of Fomes fomentarius and Ganoderma Applanatum Mushrooms Showing Therapeutic Properties. Bilge Int. J. Sci. Technol. Res. 2024, 8, 14–18. [Google Scholar] [CrossRef]
  47. Lee, J.-S. Effects of Fomes fomentarius Supplementation on Antioxidant Enzyme Activities, Blood Glucose, and Lipid Profile in Streptozotocin-Induced Diabetic Rats. Nutr. Res. 2005, 25, 187–195. [Google Scholar] [CrossRef]
  48. Doğan, H.H.; Karagöz, S.; Duman, R. In Vitro Evaluation of the Antiviral Activity of Some Mushrooms from Turkey. IJM 2018, 20, 201–212. [Google Scholar] [CrossRef]
  49. Aoki, M.; Tan, M.; Fukushima, A.; Hieda, T.; Kubo, S.; Takabayashi, M.; Ono, K.; Mikami, Y. Antiviral Substances with Systemic Effects Produced by Basidiomycetes Such as Fomes fomentarius. Biosci. Biotechnol. Biochem. 1993, 57, 278–282. [Google Scholar] [CrossRef]
  50. Kolundžić, M.; Grozdanić, N.Đ.; Dodevska, M.; Milenković, M.; Sisto, F.; Miani, A.; Farronato, G.; Kundaković, T. Antibacterial and Cytotoxic Activities of Wild Mushroom Fomes fomentarius (L.) Fr., Polyporaceae. Ind. Crops Prod. 2016, 79, 110–115. [Google Scholar] [CrossRef]
  51. Rösecke, J.; König, W.A. Constituents of Various Wood-Rotting Basidiomycetes. Phytochemistry 2000, 54, 603–610. [Google Scholar] [CrossRef] [PubMed]
  52. Munro, H.D.; Musgrave, O.C. Extractives from Sporophores of Some Fomes Species. J. Chem. Soc. C 1971, 685–688. [Google Scholar] [CrossRef]
  53. Zang, Y.; Xiong, J.; Zhai, W.-Z.; Cao, L.; Zhang, S.-P.; Tang, Y.; Wang, J.; Su, J.-J.; Yang, G.-X.; Zhao, Y.; et al. Fomentarols A–D, Sterols from the Polypore Macrofungus Fomes fomentarius. Phytochemistry 2013, 92, 137–145. [Google Scholar] [CrossRef]
  54. Feng, W.; Yang, J.-S. Studies on Chemical Constituents of Fomes fomentarius (L. Ex. Fr.). Chin. Pharm. J. 2010, 45, 1528–1530. [Google Scholar]
  55. Feng, W.; Yang, J.-S. Chemical Constituents of Fomes fomentarius (L.Ex.Fr.): Part (II). Chin. Pharm. J. 2015, 50, 1090–1092. [Google Scholar] [CrossRef]
  56. Zhang, F.-L.; Shi, C.; Sun, L.-T.; Yang, H.-X.; He, J.; Li, Z.-H.; Feng, T.; Liu, J.-K. Chemical Constituents and Their Biological Activities from the Mushroom Pyropolyporus Fomentarius. Phytochemistry 2021, 183, 112625. [Google Scholar] [CrossRef]
  57. Guilger-Casagrande, M.; Lima, R. de Synthesis of Silver Nanoparticles Mediated by Fungi: A Review. Front. Bioeng. Biotechnol. 2019, 7, 287. [Google Scholar] [CrossRef]
  58. Velusamy, P.; Kumar, G.V.; Jeyanthi, V.; Das, J.; Pachaiappan, R. Bio-Inspired Green Nanoparticles: Synthesis, Mechanism, and Antibacterial Application. Toxicol. Res. 2016, 32, 95–102. [Google Scholar] [CrossRef]
  59. Robaszkiewicz, A.; Bartosz, G.; Ławrynowicz, M.; Soszyński, M. The Role of Polyphenols, β-Carotene, and Lycopene in the Antioxidative Action of the Extracts of Dried, Edible Mushrooms. J. Nutr. Metab. 2010, 2010, 173274. [Google Scholar] [CrossRef]
  60. Harhaji, L.; Mijatović, S.; Maksimović-Ivanić, D.; Stojanović, I.; Momčilović, M.; Maksimović, V.; Tufegdžić, S.; Marjanović, Ž.; Mostarica-Stojković, M.; Vučinić, Ž.; et al. Anti-Tumor Effect of Coriolus Versicolor Methanol Extract against Mouse B16 Melanoma Cells: In Vitro and in Vivo Study. Food Chem. Toxicol. 2008, 46, 1825–1833. [Google Scholar] [CrossRef]
  61. Zengin, G.; Aktumsek, A. Investigation Of Antioxidant Potentials Of Solvent Extracts From Different Anatomical Parts Of Asphodeline Anatolica E. Tuzlaci: An Endemic Plant To Turkey. Afr. J. Tradit. Complement. Altern. Med. 2014, 11, 481–488. [Google Scholar] [CrossRef]
  62. Morris, S.C. Biomimetic Materials Chemistry. Xvi. In Geological Magazine; VCH Publishers: Weinheim, Germany; Cambridge, UK; New York, NY, USA, 1996; Volume 134, pp. 877–883. ISBN 1 56081 669 4. [Google Scholar]
  63. Henglein, A. Physicochemical Properties of Small Metal Particles in Solution: “Microelectrode” Reactions, Chemisorption, Composite Metal Particles, and the Atom-to-Metal Transition. J. Phys. Chem. 1993, 97, 5457–5471. [Google Scholar] [CrossRef]
  64. Sastry, M.; Mayya, K.S.; Bandyopadhyay, K. pH Dependent Changes in the Optical Properties of Carboxylic Acid Derivatized Silver Colloidal Particles. Colloids Surf. A Physicochem. Eng. Asp. 1997, 127, 221–228. [Google Scholar] [CrossRef]
  65. Bindhu, M.R.; Umadevi, M. Synthesis of Monodispersed Silver Nanoparticles Using Hibiscus Cannabinus Leaf Extract and Its Antimicrobial Activity. Spectrochim. Acta Part. A Mol. Biomol. Spectrosc. 2013, 101, 184–190. [Google Scholar] [CrossRef]
  66. Amendola, V. Surface Plasmon Resonance of Silver and Gold Nanoparticles in the Proximity of Graphene Studied Using the Discrete Dipole Approximation Method. Phys. Chem. Chem. Phys. 2016, 18, 2230–2241. [Google Scholar] [CrossRef]
  67. Brause, R.; Möltgen, H.; Kleinermanns, K. Characterization of Laser-Ablated and Chemically Reduced Silver Colloids in Aqueous Solution by UV/VIS Spectroscopy and STM/SEM Microscopy. Appl. Phys. B Lasers Opt. 2002, 75, 711–716. [Google Scholar] [CrossRef]
  68. Kerker, M. The Optics of Colloidal Silver: Something Old and Something New. J. Colloid Interface Sci. 1985, 105, 297–314. [Google Scholar] [CrossRef]
  69. Mashwani, Z.-R.; Khan, M.A.; Khan, T.; Nadhman, A. Applications of Plant Terpenoids in the Synthesis of Colloidal Silver Nanoparticles. Adv. Colloid Interface Sci. 2016, 234, 132–141. [Google Scholar] [CrossRef]
  70. Mohan Kumar, K.; Sinha, M.; Mandal, B.K.; Ghosh, A.R.; Siva Kumar, K.; Sreedhara Reddy, P. Green Synthesis of Silver Nanoparticles Using Terminalia Chebula Extract at Room Temperature and Their Antimicrobial Studies. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2012, 91, 228–233. [Google Scholar] [CrossRef]
  71. Sowmyya, T.; Vijaya Lakshmi, G. Spectroscopic Investigation on Catalytic and Bactericidal Properties of Biogenic Silver Nanoparticles Synthesized Using Soymida Febrifuga Aqueous Stem Bark Extract. J. Environ. Chem. Eng. 2018, 6, 3590–3601. [Google Scholar] [CrossRef]
  72. Sosa, I.O.; Noguez, C.; Barrera, R.G. Optical Properties of Metal Nanoparticles with Arbitrary Shapes. J. Phys. Chem. B 2003, 107, 6269–6275. [Google Scholar] [CrossRef]
  73. Wan Mat Khalir, W.K.A.; Shameli, K.; Jazayeri, S.D.; Othman, N.A.; Che Jusoh, N.W.; Hassan, N.M. Biosynthesized Silver Nanoparticles by Aqueous Stem Extract of Entada Spiralis and Screening of Their Biomedical Activity. Front. Chem. 2020, 8, 620. [Google Scholar] [CrossRef] [PubMed]
  74. Kalitukha, L.; Sari, M. Fascinating Vital Mushrooms. Tinder Fungus (Fomes fomentarius (L.) Fr.) as a Dietary Supplement. Int. J. Res. Stud. Sci. Eng. Technol. 2019, 6, 1–9. [Google Scholar]
  75. Pylkkänen, R.; Werner, D.; Bishoyi, A.; Weil, D.; Scoppola, E.; Wagermaier, W.; Safeer, A.; Bahri, S.; Baldus, M.; Paananen, A.; et al. The Complex Structure of Fomes fomentarius Represents an Architectural Design for High-Performance Ultralightweight Materials. Sci. Adv. 2023, 9, eade5417. [Google Scholar] [CrossRef]
  76. Maniraj, A.; Kannan, M.; Rajarathinam, K.; Vivekanandhan, S.; Muthuramkumar, S. Green Synthesis of Silver Nanoparticles and Their Effective Utilization in Fabricating Functional Surface for Antibacterial Activity Against Multi-Drug Resistant Proteus Mirabilis. J. Clust. Sci. 2019, 30, 1403–1414. [Google Scholar] [CrossRef]
  77. Dundar, A.; Okumus, V.; Ozdemir, S.; Celik, K.S.; Boğa, M.; Ozcagli, E. Determination of Cytotoxic, Anticholinesterase, Antioxidant and Antimicrobial Activities of Some Wild Mushroom Species. Cogent Food Agric. 2016, 2, 1178060. [Google Scholar] [CrossRef]
  78. İrez, E.İ.; Doğru, N.H.; Demir, N. Fomes fomentarius (L.) Fr. Extracts as Sources of an Antioxidant, Antimicrobial and Antibiofilm Agents. Biol. Nyssana 2021, 12, 55. [Google Scholar] [CrossRef]
  79. Debnath, G.; Das, P.; Saha, A.K. Green Synthesis of Silver Nanoparticles Using Mushroom Extract of Pleurotus Giganteus: Characterization, Antimicrobial, and α-Amylase Inhibitory Activity. BioNanoScience 2019, 9, 611–619. [Google Scholar] [CrossRef]
  80. Zhang, L.; Wei, Y.; Wang, H.; Wu, F.; Zhao, Y.; Liu, X.; Wu, H.; Wang, L.; Su, H. Green Synthesis of Silver Nanoparticles Using Mushroom Flammulina Velutipes Extract and Their Antibacterial Activity Against Aquatic Pathogens. Food Bioprocess Technol. 2020, 13, 1908–1917. [Google Scholar] [CrossRef]
  81. Aygün, A.; Özdemir, S.; Gülcan, M.; Cellat, K.; Şen, F. Synthesis and Characterization of Reishi Mushroom-Mediated Green Synthesis of Silver Nanoparticles for the Biochemical Applications. J. Pharm. Biomed. Anal. 2020, 178, 112970. [Google Scholar] [CrossRef]
  82. Mukherjee, P.; Ahmad, A.; Mandal, D.; Senapati, S.; Sainkar, S.R.; Khan, M.I.; Parishcha, R.; Ajaykumar, P.V.; Alam, M.; Kumar, R.; et al. Fungus-Mediated Synthesis of Silver Nanoparticles and Their Immobilization in the Mycelial Matrix: A Novel Biological Approach to Nanoparticle Synthesis. Nano Lett. 2001, 1, 515–519. [Google Scholar] [CrossRef]
  83. Basavaraja, S.; Balaji, S.D.; Lagashetty, A.; Rajasab, A.H.; Venkataraman, A. Extracellular Biosynthesis of Silver Nanoparticles Using the Fungus Fusarium Semitectum. Mater. Res. Bull. 2008, 43, 1164–1170. [Google Scholar] [CrossRef]
  84. Sangappa, M.; Thiagarajan, P. Mycobiosynthesis and Characterization of Silver Nanoparticles from Aspergillus Niger: A Soil Fungal Isolate. Int. J. Life Sci. Biotechnol. Pharma Res. 2012, 1, 282–289. [Google Scholar]
  85. Lotfy, W.A.; Alkersh, B.M.; Sabry, S.A.; Ghozlan, H.A. Biosynthesis of Silver Nanoparticles by Aspergillus Terreus: Characterization, Optimization, and Biological Activities. Front. Bioeng. Biotechnol. 2021, 9, 633468. [Google Scholar] [CrossRef] [PubMed]
  86. Yassin, M.A.; Elgorban, A.M.; El-Samawaty, A.E.-R.M.A.; Almunqedhi, B.M.A. Biosynthesis of Silver Nanoparticles Using Penicillium Verrucosum and Analysis of Their Antifungal Activity. Saudi J. Biol. Sci. 2021, 28, 2123–2127. [Google Scholar] [CrossRef] [PubMed]
  87. Devanesan, S.; AlSalhi, M.S. Green Synthesis of Silver Nanoparticles Using the Flower Extract of Abelmoschus Esculentus for Cytotoxicity and Antimicrobial Studies. Int. J. Nanomed. 2021, 16, 3343–3356. [Google Scholar] [CrossRef]
  88. Nedelcu, I.-A.; Ficai, A.; Sonmez, M.; Ficai, D.; Oprea, O.; Andronescu, E. Silver Based Materials for Biomedical Applications. Curr. Org. Chem. 2014, 18, 173–184. [Google Scholar] [CrossRef]
  89. Misra, S.K.; Dybowska, A.; Berhanu, D.; Luoma, S.N.; Valsami-Jones, E. The Complexity of Nanoparticle Dissolution and Its Importance in Nanotoxicological Studies. Sci. Total Environ. 2012, 438, 225–232. [Google Scholar] [CrossRef]
  90. Al-Hamadani, A.H.; Kareem, A.A. Combination Effect of Edible Mushroom €“ Sliver Nanoparticles and Antibiotics against Selected Multidrug Biofilm Pathogens. Iraq Med. J. 2017, 1, 68–74. [Google Scholar]
  91. Wu, H.; Lin, J.; Liu, P.; Huang, Z.; Zhao, P.; Jin, H.; Ma, J.; Wen, L.; Gu, N. Reactive Oxygen Species Acts as Executor in Radiation Enhancement and Autophagy Inducing by AgNPs. Biomaterials 2016, 101, 1–9. [Google Scholar] [CrossRef]
  92. Markowska, K.; Grudniak, A.; Wolska, K. Silver Nanoparticles as an Alternative Strategy against Bacterial Biofilms. Acta Biochim. Pol. 2013, 60, 523–530. [Google Scholar] [CrossRef] [PubMed]
  93. Joshi, A.S.; Singh, P.; Mijakovic, I. Interactions of Gold and Silver Nanoparticles with Bacterial Biofilms: Molecular Interactions behind Inhibition and Resistance. Int. J. Mol. Sci. 2020, 21, 7658. [Google Scholar] [CrossRef] [PubMed]
  94. Ahmad, A.; Wei, Y.; Syed, F.; Tahir, K.; Rehman, A.U.; Khan, A.; Ullah, S.; Yuan, Q. The Effects of Bacteria-Nanoparticles Interface on the Antibacterial Activity of Green Synthesized Silver Nanoparticles. Microb. Pathog. 2017, 102, 133–142. [Google Scholar] [CrossRef] [PubMed]
  95. El Messaoudi, N.; Ciğeroğlu, Z.; Şenol, Z.M.; Bouich, A.; Kazan-Kaya, E.S.; Noureen, L.; Américo-Pinheiro, J.H.P. Chapter Fourteen—Green Synthesis of Nanoparticles for Remediation Organic Pollutants in Wastewater by Adsorption. In Advances in Chemical Pollution, Environmental Management and Protection; Kumar, A., Bilal, M., Ferreira, L.F.R., Eds.; Elsevier: Amsterdam, The Netherlands, 2024; Volume 10, pp. 305–345. ISBN 2468-9289. [Google Scholar]
  96. Shah, Z.; Gul, T.; Ali Khan, S.; Shaheen, K.; Anwar, Y.; Suo, H.; Ismail, M.; Alghamdi, K.M.; Salman, S.M. Synthesis of High Surface Area AgNPs from Dodonaea Viscosa Plant for the Removal of Pathogenic Microbes and Persistent Organic Pollutants. Mater. Sci. Eng. B 2021, 263, 114770. [Google Scholar] [CrossRef]
  97. Wypij, M.; Jędrzejewski, T.; Trzcińska-Wencel, J.; Ostrowski, M.; Rai, M.; Golińska, P. Green Synthesized Silver Nanoparticles: Antibacterial and Anticancer Activities, Biocompatibility, and Analyses of Surface-Attached Proteins. Front. Microbiol. 2021, 12, 632505. [Google Scholar] [CrossRef]
  98. Zhao, L.-J.; Yu, R.-J.; Ma, W.; Han, H.-X.; Tian, H.; Qian, R.-C.; Long, Y.-T. Sensitive Detection of Protein Biomarkers Using Silver Nanoparticles Enhanced Immunofluorescence Assay. Theranostics 2017, 7, 876–883. [Google Scholar] [CrossRef]
  99. Hussein, H.A.; Abdullah, M.A. Novel Drug Delivery Systems Based on Silver Nanoparticles, Hyaluronic Acid, Lipid Nanoparticles and Liposomes for Cancer Treatment. Appl. Nanosci. 2022, 12, 3071–3096. [Google Scholar] [CrossRef]
  100. Weinstein, M.P.; Patel, J.B. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: M07-A11, 11th ed.; Documents/Clinical and Laboratory Standards Institute; Committee for Clinical Laboratory Standards: Wayne, PA, USA, 2018; ISBN 978-1-56238-836-2. [Google Scholar]
Figure 1. UV-Vis spectra of AgNPs synthesized via F. fomentarius L. Fr. extract at different time intervals.
Figure 1. UV-Vis spectra of AgNPs synthesized via F. fomentarius L. Fr. extract at different time intervals.
Molecules 29 03961 g001
Figure 2. FT-IR spectra of dried Fomes fomentarius L. Fr. extract and AgNPs synthesized via F. fomentarius L. Fr. extract.
Figure 2. FT-IR spectra of dried Fomes fomentarius L. Fr. extract and AgNPs synthesized via F. fomentarius L. Fr. extract.
Molecules 29 03961 g002
Figure 3. PXRD pattern of AgNPs synthesized via F. fomentarius L. Fr. extract.
Figure 3. PXRD pattern of AgNPs synthesized via F. fomentarius L. Fr. extract.
Molecules 29 03961 g003
Figure 4. (A) TEM image showing the AgNPs synthesized via F. fomentarius L. Fr. extract with a size distribution of approximately 23.6 ± 3.5 nm. (B) TEM image processed using the “Find Edges” option in the Fiji program (an extension of the ImageJ program). The edge detection enhances the sharpness of the image by defining the particle boundaries more clearly against the background, making the nanoparticles appear more distinct. The scale bar represents 100 nm in A and B images. (C) Average particle size of AgNPs synthesized via F. fomentarius L. Fr. extract.
Figure 4. (A) TEM image showing the AgNPs synthesized via F. fomentarius L. Fr. extract with a size distribution of approximately 23.6 ± 3.5 nm. (B) TEM image processed using the “Find Edges” option in the Fiji program (an extension of the ImageJ program). The edge detection enhances the sharpness of the image by defining the particle boundaries more clearly against the background, making the nanoparticles appear more distinct. The scale bar represents 100 nm in A and B images. (C) Average particle size of AgNPs synthesized via F. fomentarius L. Fr. extract.
Molecules 29 03961 g004
Figure 5. Fomes fomentarius L. Fr.
Figure 5. Fomes fomentarius L. Fr.
Molecules 29 03961 g005
Table 1. Minimum inhibitory concentrations (MIC) of methanolic extract of Fomes fomentarius L. Fr. and AgNPs synthesized using methanolic extract of Fomes fomentarius L. Fr. against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, and Staphylococcus aureus (µg mL−1).
Table 1. Minimum inhibitory concentrations (MIC) of methanolic extract of Fomes fomentarius L. Fr. and AgNPs synthesized using methanolic extract of Fomes fomentarius L. Fr. against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, and Staphylococcus aureus (µg mL−1).
MIC (µg mL−1)
B. subtilisS. aureusE. coliP. aeruginosa
Fomes fomentarius MetOH extract *20.8310.412.6320.83
AgNPs 12.696.3412.6912.69
Ciprofloxacin1.563.133.137.89
* Results expressed as mg mL−1.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Pavić, V.; Kovač-Andrić, E.; Ćorić, I.; Rebić, S.; Užarević, Z.; Gvozdić, V. Antibacterial Efficacy and Characterization of Silver Nanoparticles Synthesized via Methanolic Extract of Fomes fomentarius L. Fr. Molecules 2024, 29, 3961. https://doi.org/10.3390/molecules29163961

AMA Style

Pavić V, Kovač-Andrić E, Ćorić I, Rebić S, Užarević Z, Gvozdić V. Antibacterial Efficacy and Characterization of Silver Nanoparticles Synthesized via Methanolic Extract of Fomes fomentarius L. Fr. Molecules. 2024; 29(16):3961. https://doi.org/10.3390/molecules29163961

Chicago/Turabian Style

Pavić, Valentina, Elvira Kovač-Andrić, Ivan Ćorić, Stella Rebić, Zvonimir Užarević, and Vlatka Gvozdić. 2024. "Antibacterial Efficacy and Characterization of Silver Nanoparticles Synthesized via Methanolic Extract of Fomes fomentarius L. Fr." Molecules 29, no. 16: 3961. https://doi.org/10.3390/molecules29163961

Article Metrics

Back to TopTop